Colleen O'Brien has an extensive background in toxicology research and preclinical safety assessment, with experience in various roles at Vertex Pharmaceuticals, Elixir Pharmaceuticals, Toxikon Corporation, Charles River Laboratories, Biomedical Research Models Inc., Clark University, and UMass Medical School. Colleen holds a Bachelor's degree in Biology from Clark University.
February, 2023 - present
December, 2021
February, 2021
May, 2015
October, 2012
July, 2010
July, 2009
April, 2009